The Cancer Genome Atlas has sifted through some 500 samples of 20 different types of cancer in an effort to uncover what makes different cancers tick, but a recent study in Nature estimates that that effort may have only scratched the surface, writes Carl Zimmer at the New York Times.

"The Cancer Genome Atlas has been a spectacular success, there's no doubt about that,” Bruce Stillman, the president of Cold Spring Harbor Laboratory, tells Zimmer

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: association between genome-wide homozygosity and traits like height and cognitive ability, improved CRISPR-Cas9 editing, and more.

A survey examines how age, political leanings, and more influence how Americans view certain scientific topics, the Associated Press reports.

A researcher who pleaded guilty to making false statements in research reports has been sentenced to four and a half years in prison and must pay $7.2 million back to the NIH.

The BabySeq project to study the risks and benefits of sequencing newborns is underway.